Table 2.

EGFR, KRAS, BRAF, and HER-2 mutation status in brain metastases from breast, kidney, and colorectal primitive tumors and patient characteristics

				Mutation status in brain metastases
Primitive anatomical location	No	Sex	Age	EGFR	KRAS	BRAF	HER-2
Breast	BM70	F	79	wt	wt	wt	wt
	BM71	F	63	wt	wt	wt	wt
	BM72	F	63	wt	wt	wt	wt
	BM73	F	71	wt	wt	wt	wt
	BM74	F	40	wt	wt	wt	wt
	BM75	F	37	wt	wt	wt	wt
	BM76	F	60	wt	wt	wt	wt
Kidney	BM77	M	50	wt	wt	wt	wt
	BM78	M	67	wt	wt	wt	wt
	BM79	F	69	wt	wt	wt	wt
	BM80	F	57	wt	wt	wt	wt
	BM81	M	64	wt	wt	wt	wt
	BM82	F	57	wt	wt	wt	wt
Colorectal	BM83	F	77	wt	wt	wt	wt
	BM84	M	67	wt	wt	V600E	wt
	BM85	F	80	wt	G13D	wt	wt
	BM86	M	58	wt	wt	V600E	wt
	BM87	M	59	wt	G12A	wt	wt
	BM88	M	76	wt	G12V	wt	wt